Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
Not Applicable
Recruiting
- Conditions
- Tricuspid RegurgitationTricuspid Valve DiseaseTricuspid Valvular Disorders
- First Posted Date
- 2023-05-08
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- VDyne, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05848284
- Locations
- 🇺🇸
Los Robles Hospital and Medical Center, Thousand Oaks, California, United States
🇺🇸Henry Ford Hospital, Detriot, Michigan, United States
🇺🇸Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
Not Applicable
Recruiting
- Conditions
- Tricuspid RegurgitationTricuspid Valve DiseaseTricuspid Valvular Disorders
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- VDyne, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05797519
- Locations
- 🇦🇺
St. Vincent Hospital, Sydney, New South Wales, Australia
🇦🇺Flinders Medical Centre, Adelaide, Australia
🇦🇺Princess Alexandra Hospital, Brisbane, Australia
News
No news found